We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP38732
Abstract: CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. They can be designed as ready-to-use panels or as customized assays. We are dedicated to providing the highest level of sequencing services. With various solution options and experienced scientists, we offer the most suitable strategies according to your sample and research purpose.Summary: Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. References: https://www.cd-genomics.com/diseasepanel/massarray.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
How to Sequence the Immune Repertoire?
CD Genomics
The Time is Now for Bacteriophage Research
CD Genomics
Beyond Sequencing CRISPR Gene Editing Assessment and Quality Control Using Next-Generation Sequencing
CD Genomics
H2N2 is the new wily virus driving people to hospitals
Anmol Chipa
AN OVERVIEW OF NANOTECHNOLOGY IN PHARMACY
Utpal Bhui